Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -74.27% vs 23.91% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
No Fixed Assets in the last few periods;
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 452.97% vs 569.12% in Mar 2024
Compare Balance Sheet Results of Kabra Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
23.71
18.13
5.58
30.78%
Share Warrants & Outstandings
Total Reserve
0.95
37.49
-36.54
-97.47%
Shareholder's Funds
24.65
55.62
-30.97
-55.68%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
6.76
-6.76
-100.00%
Secured Loans
0.00
5.49
-5.49
-100.00%
Unsecured Loans
0.00
1.27
-1.27
-100.00%
Deferred Tax Assets / Liabilities
0.00
3.14
-3.14
-100.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.00
9.90
-9.90
-100.00%
Current Liabilities
Trade Payables
0.00
16.73
-16.73
-100.00%
Other Current Liabilities
0.14
3.30
-3.16
-95.76%
Short Term Borrowings
0.44
5.70
-5.26
-92.28%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
0.57
25.73
-25.16
-97.78%
Total Liabilities
25.23
91.25
-66.02
-72.35%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.05
40.90
-40.85
-99.88%
Less: Accumulated Depreciation
0.01
0.00
0.01
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.04
40.90
-40.86
-99.90%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.02
0.00
0.02
0.00%
Other Non Current Assets
0.00
1.16
-1.16
-100.00%
Total Non-Current Assets
0.07
42.06
-41.99
-99.83%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.00
16.10
-16.10
-100.00%
Sundry Debtors
0.60
20.23
-19.63
-97.03%
Cash and Bank
21.30
8.61
12.69
147.39%
Other Current Assets
0.00
4.07
-4.07
-100.00%
Short Term Loans and Advances
3.26
0.17
3.09
1,817.65%
Total Current Assets
25.16
49.19
-24.03
-48.85%
Net Current Assets (Including Current Investments)
24.59
23.46
1.13
4.82%
Total Current Assets Excluding Current Investments
25.16
49.19
-24.03
-48.85%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
25.23
91.25
-66.02
-72.35%
Contingent Liabilities
0.49
0.00
0.49
0.00%
Total Debt
0.44
12.46
-12.02
-96.47%
Book Value per share (adjusted)
10.40
30.68
-20.28
-66.10%
Annual - Borrowings
Borrowings 0.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -74.27% vs 23.91% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.04 Cr
in Mar 2025Figures in Cr
No Fixed Assets in the last few periods;
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 25.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 452.97% vs 569.12% in Mar 2024






